# GCNT3

## Overview
GCNT3 is a gene that encodes the enzyme glucosaminyl (N-acetyl) transferase 3, mucin type, which is a glycosyltransferase involved in the biosynthesis of mucin-type O-glycans. This enzyme plays a crucial role in the formation of protective mucous barriers on epithelial surfaces by catalyzing the addition of N-acetylglucosamine to specific glycan cores. It is primarily active in the Golgi apparatus, where it contributes to the synthesis of complex glycan structures that are essential for cell signaling, adhesion, and immune response. The proper functioning of GCNT3 is vital for maintaining mucosal integrity and immune function, and its dysregulation is implicated in various pathological conditions, including cancer (Fernández2018The; Chen2021Significance).

## Function
GCNT3 encodes a glycosyltransferase enzyme involved in the biosynthesis of mucin-type O-glycans, which are crucial for forming protective mucous barriers on epithelial surfaces. This enzyme catalyzes the addition of N-acetylglucosamine to core 1 and core 3 O-glycans, influencing cell signaling, adhesion, and immune response. It is primarily active in the Golgi apparatus, where it facilitates the synthesis of core 2 O-glycan, core 4 O-glycan, and I branches (Fernández2018The).

In healthy human cells, GCNT3 plays a significant role in maintaining mucosal integrity and immune function. Its activity is essential for the proper function of mucins, which are high-molecular-weight O-glycoproteins that form a protective mucosal layer on the surface of the gastrointestinal tract (Fernández2018The). GCNT3-deficient mice have shown impaired mucosal barriers and increased susceptibility to colitis, indicating its importance in maintaining mucosal health (Fernández2018The).

The enzyme's role in glycosylation processes is critical for various biological functions, including inflammatory and immune responses. Dysregulation of GCNT3 can lead to excessive mucin production, which is a hallmark of certain pathological conditions (Chen2021Significance).

## Clinical Significance
Alterations in the expression of the GCNT3 gene have been linked to various cancers, including colorectal cancer (CRC), epithelial ovarian cancer (EOC), and pancreatic cancer (PC). In CRC, GCNT3 expression is often down-regulated compared to non-pathological colon tissue. This down-regulation is associated with increased cell proliferation, adhesion, and invasion, contributing to cancer progression. Conversely, overexpression of GCNT3 in CRC cells has been shown to reduce these malignant behaviors and increase sensitivity to the chemotherapeutic agent 5-fluorouracil, suggesting a role in drug resistance (Fernández2018The).

In EOC, high levels of GCNT3 expression are associated with better clinical outcomes and response to initial therapy, indicating its potential as a prognostic factor (Fernández2018The). In pancreatic cancer, GCNT3 is overexpressed and contributes to tumor progression and metastasis by regulating the β-catenin/MUC4 axis. Knockdown of GCNT3 in pancreatic cancer cells results in reduced growth and proliferation, highlighting its role in promoting malignancy (Gupta2020Global).

GCNT3's involvement in these cancers underscores its potential as a biomarker for prognosis and a target for therapeutic intervention (Gupta2020Global; Fernández2018The).


## References


[1. (Gupta2020Global) Rohitesh Gupta, Frank Leon, Christopher M. Thompson, Ramakrishna Nimmakayala, Saswati Karmakar, Palanisamy Nallasamy, Seema Chugh, Dipakkumar R. Prajapati, Satyanarayana Rachagani, Sushil Kumar, and Moorthy P. Ponnusamy. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. British Journal of Cancer, 122(11):1661–1672, March 2020. URL: http://dx.doi.org/10.1038/s41416-020-0772-3, doi:10.1038/s41416-020-0772-3. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41416-020-0772-3)

[2. (Fernández2018The) Lara P. Fernández, Ruth Sánchez-Martínez, Teodoro Vargas, Jesús Herranz, Roberto Martín-Hernández, Marta Mendiola, David Hardisson, Guillermo Reglero, Jaime Feliu, Andrés Redondo, and Ana Ramírez de Molina. The role of glycosyltransferase enzyme gcnt3 in colon and ovarian cancer prognosis and chemoresistance. Scientific Reports, May 2018. URL: http://dx.doi.org/10.1038/s41598-018-26468-4, doi:10.1038/s41598-018-26468-4. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-26468-4)

3. (Chen2021Significance) Significance of mucin type glucosaminyl (N-acetyl) transferase 3 expression in lung squamous cell carcinoma. This article has 0 citations.